Serum KLRB1 (CD161) as a discriminative biomarker in community-acquired pneumonia
Serum KLRB1 may serve as a valuable biomarker to differentiate between viral and bacterial CAP, supporting early diagnosis and optimized treatment decisions.
Serum KLRB1 may serve as a valuable biomarker to differentiate between viral and bacterial CAP, supporting early diagnosis and optimized treatment decisions.
h-index: Number of publications with at least h citations each.